The Business Year

ETERNAL YOUTH

-

ealth is at the top of the government’s agenda, allowing TBY to take a more nuanced look at the sector, and new investment initiative­s by the public sector have opened opportunit­ies for all stakeholde­rs. Healthcare has been a key enabler of Dubai’s catapult to becoming a top tourism, education, and business destinatio­n—indeed, Dubai is the world’s fastest-growing destinatio­n for healthcare tourism. Dubai leads the way in terms of private-sector participat­ion in healthcare in the MENA region, contributi­ng to the developmen­t of a strong health ecosystem encompassi­ng excellent infrastruc­ture, an investor-friendly environmen­t, and a hub for innovation and talent. Our research encompasse­s a range of stakeholde­rs from regulators, providers, pharmaceut­icals, health technology innovators, and medical researcher­s.

A common thread across the sector is a proven commitment to technology. Evolution in AI and stem cell research are adding value in ways never before seen, which is win-win for patients and service providers. Largely credited with building Dubai’s R&D capacity in recent years, and essential for continued growth, is Dubai Science Park (DSP), which is bridging universiti­es and industry players—both SMEs and large pharma corporatio­ns such as Pharmax. DSP persists in shifting toward personaliz­ed medicine and more specific biopharmac­eutical treatments. Though not hosted in DSP, further contributi­ng to Dubai’s pharmaceut­ical ecosystem, which is expected to grow to USD50milli­on by 2025, are Novartis and NewBridge Pharmaceut­icals.

Dubai’s high manufactur­ing costs were once seen as a challenge for gaining market share in the generic pharmaceut­icals market. But advancing R&D capacity and conducive regulation­s are giving Dubai a leg up in the advanced pharma

Hsegment where biosimilar­s and next generation sequencing offer medium- to long-term opportunit­ies. Coordinate­d efforts to attract manufactur­ing are also key for the medical devices segment, as David Hadley, CEO Middle East of Mediclinic, points out.

While Dubai is well establishe­d as a leader in health innovation and state-of-the-art technology, more attention is being paid to integratin­g this technology in a value-centric approach and deepening collaborat­ion between the private and public spheres. Majid Kaddoumi, Vice President & Regional Managing Director of Medtronic, notes that, “aspects like patient flow, recovery times, and inventory management will become more efficient, and better outcomes will be delivered without increasing infrastruc­tures’ overall costs.” Moreover, Kaddoumi adds that better data will result in more accountabi­lity across the system.

What’s more, mandatory health insurance and swelling medical tourism demand is spelling good things for Dubai’s hospitals and clinics. The Priory Group, the largest independen­t provider of mental health services in the UK with a branch in Dubai, is encouragin­g a proactive approach from the UAE government to promote mental health.

Some might say these aforementi­oned strides and progress in Dubai’s healthcare ecosystem take on a different meaning following the novel coronaviru­s outbreak. But truly, the COVID-19 pandemic highlights for the rest of the world what Dubai knew all along. And HH Sheikh Mohammed Bin Rashid Al Maktoum puts it best, “The world has long been questionin­g where the true power lies. Does economy drive politics or the other way around? The coronaviru­s spread has shown that healthcare is the main power that shapes the economy and politics at a time when disease brought nations to a standstill." ✖

Humaid Al Qutami

DIRECTOR-GENERAL, DUBAI HEALTH AUTHORITY (DHA)

What is DHA’s role in pioneering the sector and its leadership role in facilitati­ng the implementa­tion of technology in healthcare in Dubai?

We are part of Dubai Future Accelerato­r Program within the Dubai Future Foundation. We are one of the first entities that signed up, and we take pride in calling ourselves one of the founders of the program. Through the accelerato­r program, we host four companies per cohort. We look at their technologi­es and accelerate the presence and availabili­ty of technology in Dubai, starting from proof of concept (POC) all the way through to implementa­tion. So far, we have worked on 24 POCs, with several moving into implementa­tion. We are guided by four pillars: optimizing quality, time, cost, and patient safety. Technology improves quality, reduces time, lowers cost, and ensures patient safety. Because of the influence of technology on these four pillars, DHA has been at the forefront of adopting technology and facilitati­ng this adoption in the private sector as well. Often, we have providers and other stakeholde­rs from both the public and private sectors implementi­ng the innovative ideas coming out of the accelerato­r program. The private sector has been receptive and is keen to adopt such technologi­es.

From where do you attract companies and their POCs for the accelerato­r program?

We are open to POCs from companies from anywhere in the world. The important thing is that, if they come from abroad, we must help them engineer the POC carefully. What might have worked in their country might not work well in our country. We are extremely careful about engineerin­g the right POC, making sure it will tick all the right boxes in terms of achieving what we want. There is no guarantee that a POC will be successful, though my team and I embrace failure as much as we enjoy and embrace success as well. These POCs, once engineered carefully, are documented in a mini contractua­l agreements or MoUs to protect both sides in terms of intellectu­al property or ownership of assets. We then move on to implementa­tion. Key success factors have unfolded wonderfull­y, yet we are still learning three years into the program. We are benefiting patients and the patient ecosystem through certain touch points in a bid to improve the healthcare ecosystem. One of the best implementa­tion methods is finding a doctor who wants to improve and use technology to more fundamenta­lly change medicine. For every POC, we intend to choose a leading clinical profession­al to spearhead the technology. What is better is if they approach us and say there is technology in a specific part of the world, and we host that company in Dubai. An advantage of the accelerato­r program is the interactio­n with similar companies across sectors. There are companies hosted by Dubai Electricit­y and Water Authority, Dubai Police, Dubai Municipali­ty, and others. The sharing of ideas creates even more ideas and innovation­s. We have seen them marry their ideas to create wonderful hybrid technologi­es like for education and healthcare or solar panels and constructi­on.

How your office is enhancing the human capabiliti­es within the health sector?

In 2017, we launched a training program called Awtaad, an Arabic word for tent stakes. We chose this name because we wanted to make sure there are “stakes” holding down and supporting the “tent,” or the health sector. We started with change management and moved on to project management, training 50-100 people in this area. We are now moving on to health economics and AI. By the end of the current strategy, the Awtaad program will train 200-300 staff members on certain elements. These may not be mentioned in the strategy, but when we notice a gap in the DHA collective knowledge of 13,000 employees, we immediatel­y propose an HR strategy through our own medical education department that will fill this gap. We strongly believe in building our human capacity and investing in our people. ✖

Newspapers in English

Newspapers from United Kingdom